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ABSTRACT ThegenusClostridiumincludesmajorhumanpathogensandspeciesimportanttocellulosedegradation,thecarbon
cycle,andbiotechnology.SmallRNAs(sRNAs)areemergingascrucialregulatorymoleculesinallorganisms,buttheyhavenot
beeninvestigatedinclostridia.ResearchonsRNAsinclostridiaishinderedbytheabsenceofasystematicmethodtoidentify
sRNAcandidates,thusdelegatingclostridialsRNAresearchtoahit-and-missprocess.Thus,wewantedtodevelopamethodto
identifypotentialsRNAsinthe ClostridiumgenustoopenuptheﬁeldofsRNAresearchinclostridia.Usingcomparativegenom-
icsanalysescombinedwithpredictionsofrho-independentterminatorsandpromoters,wepredictedsRNAsin21clostridial
genomes: Clostridium acetobutylicum, C. beijerinckii, C. botulinum (eight strains), C. cellulolyticum, C. difﬁcile, C. kluyveri
(two strains), C. novyi, C. perfringens (three strains), C. phytofermentans, C. tetani, and C. thermocellum. Although more than
one-thirdofpredictedsRNAshaveShine-Dalgarno(SD)sequences,onlyone-sixthhaveastartcodondownstreamofSDse-
quences;thus,mostofthepredictedsRNAsarenoncodingRNAs.Quantitativereversetranscription-PCR(Q-RT-PCR)and
NorthernanalysiswereemployedtotestthepresenceofarandomlychosensetofsRNAsin C.acetobutylicumandseveral
C. botulinum strains, leading to the conﬁrmation of a large fraction of the tested sRNAs. We identiﬁed a conserved, novel sRNA
which,togetherwiththedownstreamgenecodingforanATP-bindingcassette(ABC)transportergene,respondstotheantibi-
oticclindamycin.ThenumberofpredictedsRNAscorrelatedwiththephysiologicalfunctionofthespecies(highforpathogens,
lowforcellulolytic,andintermediateforsolventogenic),butnotwith16SrRNA-basedphylogeny.
IMPORTANCE Clostridiaincludemajorhumanpathogensandspeciesimportanttohumanphysiology,cellulosedegradation,the
carboncycle,andbiotechnology.SmallRNAs(sRNAs)areincreasinglyrecognizedascrucialregulatorymoleculesinallorgan-
isms,buttheyremainvirtuallyunexploredinclostridia.Weprovidetheﬁrstcomprehensivelistofcomputationallyidentiﬁed
andexperimentallyveriﬁedsmallRNAsinthegenus ClostridiumaimingtoaccelerateinterestinandstudiesofsmallRNAmole-
culesinaveryimportantgenus.ThehighernumberofsRNAsfoundinclostridialpathogenssuggestsagoodcorrelationbe-
tweenthephysiologicalfunctionornicheofthespeciesandthenumberofpredictedandconservedsRNAs.Ourlistofpredicted
sRNAsdisplaysastrongenrichmentofsRNAsupstreamordownstreamofATP-bindingcassette(ABC)transportergenes.This,
combinedwiththeidentiﬁcationofaconservedsRNAapparentlyinvolvedinclindamycinresistance,providesanewperspective
forfuturestudiesofpossibleregulationofantibioticresistancegenesbysRNAsinbacteria.
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P
rokaryotic small RNAs (sRNAs) play important regulatory
roles in a variety of cellular processes. They are typically 50 to
500nucleotides(nt)inlengthandarefoundonintergenicregions
(IRs) (1). Most of these functional RNA molecules normally do
not possess a protein-coding function, but some do. They typi-
cally act as posttranscriptional regulators by interacting with spe-
ciﬁcmRNAtargets,modulatingtargetstabilityand/ortranslation
initiation (2). Since the discovery of regulatory sRNA in Esche-
richia coli (3, 4), several genome-wide methods for sRNA discov-
ery have been developed by combining computational searches
with experimental validation of select candidates (5, 6). Using a
comparative genomics screen approach, Rivas et al. (7) predicted
275 sRNAs in E. coli, and more than 11 out of the 49 tested candi-
dates were experimentally veriﬁed. With the availability of an in-
creasing number of bacterial genome sequences, such strategies
have been employed for the discovery of many sRNAs not only in
E. coli but also in other prokaryotes (8–13). Most methods that
have been developed to predict prokaryotic sRNAs (14–16) em-
ploy comparative genomics approaches and have typically been
applied to a few genomes in the members of a genus. In addition,
most rely solely on comparative genome screening and typically
identifyhighlyconservedsRNAs.Promoterandterminatorinfor-
mation, which can be important in identifying the length and
orientation of sRNAs, is rarely used in such predictions. Two of
the most successful predictive tools are the comparative
genomics-based computational tools sRNAPredict (17) and
SIPHT (18), which combine the positions of various predictive
features of sRNAs to predict IR-located sRNAs and which were
developed by Linvy et al.
Clostridium is an important prokaryotic genus which includes
manyspeciesfoundinsoil,nonpathogenicspecies,andimportant
human and animal pathogens (19). The genus also includes
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bioremediation(20–22).Forexample,Clostridiumacetobutylicum
was used to produce acetone and biobutanol from carbohydrates
up to the 1950s using the ABE process (acetone butanol ethanol
process),andtherehasbeenrecentinterestinusingthisspeciesin
biofuelproduction(21,22),whilecellulolyticclostridiaareviewed
as important industrial organisms for production of chemicals
andbiofuelsfromcellulosicfeedstocks(23).Littleisknownabout
regulatorysRNAsinclostridia.InC.perfringens,aregulatoryRNA
molecule (VR-RNA) was found to be responsible for the tran-
scriptional regulation of two toxin genes, the collagenase (colA)
and alpha-toxin (plc) genes (24). In C. saccharobutylicum P262,
expression of the glutamine synthetase gene (glnA) was found to
be regulated by an antisense RNA molecule transcribed from
downstream and in the direction opposite that of glnA (25–27). A
stand-aloneS-boxandaT-boxriboswitchwereshowntoregulate
a sulfur metabolic operon of C. acetobutylicum based on an
antisense-RNA mechanism (28). In C. acetobutylicum, a likely
synthetic noncoding RNA was found to improve the resistance to
thetoxicityofbutyrateandothercarboxylicacids(29).Recently,it
was reported that a small noncoding RNA on the pSOL1
megaplasmid of C. acetobutylicum regulates the expression of sol-
vent genes (30).
Inthisstudy,wecomputationallypredictedsRNAsinvirtually
all clostridial genomes sequenced until late 2009 (when the com-
putationalworkofthisstudywascompleted),21intotal:Clostrid-
ium acetobutylicum, C. beijerinckii, C. botulinum (eight strains),
C. cellulolyticum, C. difﬁcile, C. kluyveri (two strains), C. novyi,
C. perfringens (three strains), C. phytofermentans, C. tetani, and
C. thermocellum. The approach integrated and combined genetic
featuresofsequenceconservationandnotablypredictionsoftran-
scriptional terminators and clostridial promoters. We show that
most predicted clostridial sRNA sequences are well conserved
only in the genus Clostridium and cannot be identiﬁed in the ge-
nomes of species that are phylogenetically close to clostridia like
Bacillus subtilis. We experimentally validated a randomly selected
set of predicted sRNAs from C. acetobutylicum and three C. botu-
linum strains. An interesting discovery is a novel sRNA, upstream
of an ATP-binding cassette (ABC) transporter gene, which is ap-
parently involved in the antibiotic response to clindamycin and
can be identiﬁed in several clostridial genomes.
RESULTS
Prediction of sRNAs on clostridial genomes. Predicted sRNAs
on virtually all sequenced clostridial genomes are summarized in
Table 1, and a detailed list of predicted sRNA candidates is shown
in Table S1 (Excel) in the supplemental material. In total, 113
sRNAs were predicted in Clostridium acetobutylicum, 101 on the
chromosome and 12 on the pSOL1 megaplasmid, which carries
the essential genes for production of solvent (butanol, acetone,
and ethanol) (31), the characteristic stationary-phase trait of sol-
ventogenic clostridia. Comparing our prediction to the predicted
and annotated RNA sequences in the Rfam database (v9.1), we
found that 32 of our predicted sequences had also been predicted
byRfamtobemembersofknownRNAfamilies,whichinclude16
riboswitches (thiamine pyrophosphate [TPP], ﬂavin mononucle-
otide [FMN], cobalamin, S-adenosylmethionine [SAM], purine,
lysine), 12 upstream leaders (L10_leader, L20_leader, T-box, and
ykoK),onesRNAparticipatinginsignalrecognitionparticlecom-
plex (SRP_bact), one ribozyme (RNaseP_bact_a), and two other
sRNAs(6SandtmRNA[namedforitsdualtRNAandmRNA-like
nature]). In Clostridium botulinum, more than 200 sRNAs were
predicted in each strain (see Table S1 in the supplemental mate-
rial). Of these sRNAs, 31 overlap with the Rfam predictions, in-
TABLE 1 Summary of predicted clostridial sRNAs
Organism
No. of predicted sRNAs
(excludes tRNAs)
Genome size
(bp)
No. of
genes
Avg IR
size (bp)
No. of genes that
overlap with Rfam (v9.1)
(excludes tRNAs)a
Pathogenic
C. botulinum A ATCC 3502 219 3,903,260 3,590 195 31
C. botulinum A ATCC 19397 233 3,863,450 3,551 198 31
C. botulinum A Hall 231 3,760,560 3,404 210 31
C. botulinum A3 Loch Maree 249 4,259,691 3,984 200 N/A
C. botulinum B1 okra 246 4,107,013 3,852 209 N/A
C. botulinum B Eklund 245 3,847,969 3,520 201 N/A
C. botulinum E3 Alaska E43 251 3,659,644 3,256 194 N/A
C. botulinum F Langeland 257 4,012,918 3,659 208 31
C. difﬁcile 630 264 4,298,133 3,753 194 31
C. novyi NT 119 2,547,720 2,315 146 30
C. perfringens 13 193 3,085,740 2,723 184 26
C. perfringens ATCC 13124 181 3,256,683 2,876 183 30
C. perfringens SM101 131 2,921,996 2,578 204 12
C. tetani E88 137 2,873,333 2,432 171 32
Solventogenic and C. kluyveri
C. acetobutylicum ATCC 824 113 4,132,880 3,848 153 32
C. beijerinckii NCIMB 8052 336 6,000,632 5,020 240 27
C. kluyveri DSM 555 126 4,023,800 3,913 161 41
C. kluyveri NBRC 12016 136 3,955,303 3,523 186 N/A
Cellulolytic
C. cellulolyticum H10 45 4,068,724 3,390 159 N/A
C. phytofermentans ISDg 42 4,847,594 3,902 228 N/A
C. thermocellum ATCC 27405 15 3,843,301 3,189 197 12
a N/A, not available.
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upstreamleaders(L10_leader,L20_leader,T-box,andykoK),one
SRP_bact, and one RNaseP_bact_a.
To examine whether the predicted sRNA sequences could en-
code small proteins, Shine-Dalgarno (SD) sequences were
searched for (32) in the 5= region of the predicted sequence. The
result shows that more than one-third of the predicted sequences
have SD sequences near their 5= end. However, only one-sixth of
thepredictedsRNAsequenceshaveastartcodonfollowingtheSD
sequences.Evenintheselattersequences,somecontainmanystop
codons (e.g., sCAC0610), while others (e.g., sCAC1074 and
sCAC2470) have structures similar to known sRNA families
(sRNA names explained below in “siRNA nomenclature” in Ma-
terials and Methods). Therefore, most of the predicted sRNA se-
quences do not appear to encode small protein genes.
Experimental validation of predicted sRNAs. A randomly
chosen subset of predicted sRNAs in C. acetobutylicum and
C.botulinum(severalstrains)wereexaminedforexpressionusing
quantitative reverse transcription-PCR (Q-RT-PCR) and/or
Northernanalysis(seeTableS2inthesupplementalmaterial).We
chose these clostridial species based on the interest of our lab and
thebroadercommunityinC.acetobutylicumandthedesiretoalso
include a major pathogen (C. botulinum) of great interest. Al-
thoughtherehavebeenreportsintheliterature(10,33)ontheuse
of Q-RT-PCR for validating sRNAs, there are lingering doubts as
to the suitability of Q-RT-PCR as a validation tool. Thirty and 21
of the predicted sRNAs from C. acetobutylicum and C. botulinum,
respectively, were tested using Q-RT-PCR (Fig. 1). Selection of
predicted sRNAs for validation was based on high GC content of
theirsequencetofacilitatethedesignofQ-RT-PCRprimers.Oth-
erwisetheselectionofpredictedsRNAswasrandom.Weaimedto
classify Q-RT-PCR-tested sRNAs in C. acetobutylicum into three
groups, “highly expressed,” “possibly expressed,” and “not ex-
pressed.” This classiﬁcation was based on expression proﬁles of
“control genes” that were selected using expression analysis data
fromadetailedmicroarraystudy(34),plusﬁverandomlyselected
intergenic region (IR) sequences in C. acetobutylicum that do not
belongtoanyannotatedorpredictedtranscripts.Accordingtothe
cycle threshold (CT) values determined using these “control
genes” (Fig. 1), seven sRNA candidates (Fig. 1A, genes 7 to 13)
were classiﬁed as “highly expressed,” and 13 as “possibly ex-
pressed” (Fig. 1A, genes 14 to 27) in an RNA cocktail generated
from samples taken at different time points from normal batch
cultures,andculturesstressedwitheitherbutanolorbutyrate(see
MaterialsandMethodsandFig.1).Weusedsamplesfromstressed
cultures based on the assumption that some sRNAs might be ex-
pressed under physiologically relevant stressful conditions, such
as butanol and butyrate stress (35, 36). Similarly, four IR se-
quences in C. botulinum A3 Loch Maree were used as negative
controls for testing the expression of predicted C. botulinum
sRNAs. Ten candidates from C. botulinum A3 Loch Maree, six
candidates from C. botulinum A ATCC 3502, and ﬁve candidates
from C. botulinum A Hall were tested by Q-RT-PCR using RNA
cocktails from normal, unstressed cultures. In total, six sRNAs
werefoundtobehighlyexpressedorpossiblyexpressed(Fig.1B),
four from C. botulinum A3 Loch Maree, one from C. botulinum A
ATCC 3502, and one from C. botulinum A Hall.
Among the predicted sRNAs which had relatively low CT val-
ues in the Q-RT-PCR analysis, we chose the few that have rela-
tively high GC content in order to design good quality probes for
Northernanalysis.SixsRNAsfromC.acetobutylicum(sCAC1449,
sCAC1760, sCAC3821, sCAC3340, sCAC137 [Fig. 2A and C] and
the sCAC610 sRNA discussed below) and two from C. botulinum
(sCLK_200 and sCLK_3105 [Fig. 2B]) were validated using
Northern analysis. Considering the accuracy of measuring tran-
scriptsizesusingNorthernblotting,especiallyatthelowsizerange
of 100 to 500 nt, the sizes of sCAC1760, sCAC610 (see below),
sCLK_200,andsCLK_3105weresimilartothepredictedsizes.An
additional 200-nt transcript was also observed when probing for
sCAC1760,whichispossiblyaprocessedversionofthesRNA.The
remaining sRNAs (sCAC1449, sCAC3821, and sCAC3340) were
found to have different transcript lengths than predicted. The
comparative genomics method used here to predict sRNAs can
capture only conserved core sequences, but species-dependent
variations where sRNAs are trimmed by speciﬁc nucleases (37) or
additional noncore sequences are added may exist. The observed
size(~400nt),byNorthernanalysis,ofsCAC137(aputativenon-
coding RNA of the bacterial signal recognition particle [SRP-
_bact])islongerthanpredictedbyus(313nt)orannotatedinthe
KEGGdatabase(201nt).Todeterminetheapproximatestartand
stop sites of this sRNA, we carried out Northern analysis of the
upstream CACt008 RNA and Q-RT-PCR analysis for the intra-
genic and downstream regions of this sRNA (see Fig. S1 in the
supplemental material). Northern analysis of CACt008 RNA
showed a distinct ~87-nt transcript, which is in accordance with
the annotated size in KEGG (Fig. 2C). Q-RT-PCR results from
bothprimerset1andprimerset2(Fig.S1)showedverysimilarCT
values(19.82and19.66forprimerset1and2,respectively).Taken
together, these observations suggest that the 400-nt sequence is a
stand-alone transcript transcribed from the IR between CACt008
(tRNA) and CAC0125 (dnaX; DNA polymerase III subunit /).
The IR length between the two genes is similar to the observed
length of the sRNA transcript.
Experimentally tested sRNAs were computationally classiﬁed
intoRfamsRNAfamilies(seeTablesS3andS4inthesupplemen-
talmaterial)usingGraPPLEasdescribedinTextS1inthesupple-
mental material.
AnsRNAinvolvedintheresponsetoclindamycinandsRNAs
near ABC transporter genes. Although it is beyond the scope of
this study to examine the functional roles of the predicted sRNAs
in clostridia, we carried out a preliminary study on a novel con-
served sRNA. We observed that the sCAC610 sRNA (see Table S3
inthesupplementalmaterial)ofC.acetobutylicum,whoseexpres-
sionwastestedbyQ-RT-PCRanalysis(Fig.1A,gene27),waswell
conserved on most C. botulinum genomes and on the C. beijer-
inckiigenomes(seeFig.S2Ainthesupplementalmaterial),witha
consistent location upstream of putative ABC transporter genes
(see Fig. S2B in the supplemental material). The conserved or-
tholog in C. botulinum A3 Loch Maree, sCLK_3105, was also de-
tectedbyNorthernanalysis(Fig.2B).Thedistancesbetweenthese
conservedsRNAsequencesandthedownstreamABCtransporter
geneswereveryconsistent(~185bp)(Fig.S2B),thussuggestinga
functional relationship between this sRNA and the downstream
ABC transporter genes. This potential functional relationship is
also supported by the observation that this sRNA sequence does
notexistonthegenomesofC.botulinumstrainsBEklundandE3
Alaska E43, which both lack the ABC transporter gene. Although
sCAC610 is conserved only in clostridia, the downstream ABC
transporter gene is conserved in many genera (Clostridium, Bacil-
lus, Staphylococcus, Enterococcus, Staphylococcus, Streptococcus,
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code for a protein (Lsa) that confers low-level resistance to clin-
damycin in Staphylococcus warneri and Staphylococcus sciuri (38,
39). We therefore hypothesized that the identiﬁed sRNA and the
downstream ABC transporter gene might be involved in the re-
sponseofclostridiatoclindamycin.Topursuethishypothesis,we
investigated whether clindamycin treatment affected the expres-
sion of sCAC610 and the putative clindamycin resistance gene
(CAC0510)inC.acetobutylicum.TheMICofC.acetobutylicumto
clindamycin is 10 g/ml for solid media, but it is 200 g/ml for
liquidcultures(40).Therefore,weemployedarangeofclindamy-
cin concentrations up to 100 g/ml. Expression proﬁles of
sCAC610 and CAC0528 upon clindamycin treatment were as-
sayed by Q-RT-PCR: two biological replicate experiments were
carried out, and the data were found to be statistically signiﬁcant
(P  0.0001). Compared to untreated cells, Q-RT-PCR results
showed 4- to 6.5-fold increases in expression of both sCAC610
and CAC0528 after 30 min of 50, 75, and 100 g/ml clindamycin
treatment (Fig. 3A). The differences in expression of sCAC610
and CAC0528 in treated and untreated cells were lower but still
signiﬁcant after 60 min of treatment.
Northern analysis (Fig. 3B) showed a strong, ca. 200-nt tran-
script (despite the rather high CT value of 24 in Fig. 1A) for
sCAC610. There were increased levels of sCAC610 in samples
treated with clindamycin after 30 and 60 minutes of treatment
compared to untreated samples (Fig. 3B), and interestingly, an
FIG 1 Q-RT-PCR validation of a select set of pre-
dictedsRNAsinClostridiumacetobutylicumandthree
Clostridium botulinum strains. Cycle threshold (CT)
values are shown for genes in four groups: positive-
control genes, predicted sRNAs, low-expression
genes,andnegative-controlgenes.CTvaluesareaver-
agesof5or6replicates(errorbarsrepresentstandard
deviations). The numbers shown above the symbols
(1 to 47) represent speciﬁc genes as listed below; the
gene name is given ﬁrst, and the gene number is
showninparenthesesafterthegenename.(A)Q-RT-
PCR test of sRNA expression in C. acetobutylicum us-
ing pool CAC1 as described in Text S1 in the supple-
mental material. Positive-control genes (genes 1 to 6)
include the 16S rRNA and genes known to be ex-
pressed well on the basis of microarray data (34): 16S
(1),6S(2),CAC0681(3),CAC2957(4),CAC1322(5),
and CAC2139 (6). Low- or no-expression genes (un-
dernormalcultureconditions)(genes37to42)based
on microarray data (34) include the following:
CAC3313 (37), CAP0060 (38), CAC0428 (39),
CAC1094 (40), CAC2614 (41), and CAC2179 (42).
The negative controls (genes 43 to 47) include the
following intergenic region (IR) sequences (Ig stands
for intergenic): IgCAC_1350 (43), IgCAC_232 (44),
IgCAC_2999 (45), IgCAC_2630 (46), and Ig-
CAC_2996(47).ThepredictedsRNAs(genes7to36)
include the following: sCA-P60 (7), sCAC1449 (8),
sCAC3821 (9), sCAC137 (10), sCA-P189 (11),
sCAC3283 (12), sCAC1645 (13), sCAC646 (14),
sCAC1132 (15), sCAC1582 (16), sCAC1760 (17),
sCAC2795 (18), sCAC3723 (19), sCAC903 (20),
sCAC3340 (21), sCAC3825 (22), sCAC975.1 (23),
sCAC1315 (24), sCA-P18 (25), sCAC610 (26),
sCAC2819.1 (27), sCAC1313 (28), sCA-P105 (29),
sCA-P18.1 (30), sCAC3039 (31), sCAC500 (32),
sCAC1594(33),sCAC2709(34),sCAC3850(35),and
sCAC349 (36). Notice that the values of the genes ex-
pressed well (genes 4 to 6) and the low-expression
genes (genes 37 to 42) overlap. Thus, three zones of
approximate expression are indicated: expressed (CT
 21), lowly expressed if at all (21  CT  24), and
probablynotexpressed(CT24).TheCTvalueof21
was chosen as just below the CT value of the lowest
low-expression control genes; the CT value of 24 was
chosen based on the subsequent ﬁnding (Fig. 3) that
sCAC610 represented by gene 26 is highly expressed.
(B) Q-RT-PCR test of sRNA expression in C. botuli-
numA3LochMaree,C.botulinumAATCC3502,and
C.botulinumAHallusingpoolCLK,poolCBO,andpoolCLC,respectively,asdescribedinTextS2inthesupplementalmaterial.Thepositivecontrolsinclude
23SrRNA(genes48to50)and16SrRNA(genes51to53)inthethreeC.botulinumstrains.Thenegativecontrols(genes75to78)includethefollowingintergenic
region sequences: IgCLC_2904 (75), IgCLC_2422 (76), IgCLC_2026 (77), and IgCLC_2348 (78). The predicted sRNAs (genes 54 to 74) are sCLK_200 (54),
sCLK_3269 (55), sCLK_3642 (56), sCBO3039 (57), sCLC_2889 (58), sCLK_3105 (59), sCLK_3427 (60), sCBO2696 (61), sCLK_3557 (62), sCBO3480 (63),
sCBO1976 (64), sCLK_2040 (65), sCLK_2759 (66), sCLC_3353 (67), sCLC_1905 (68), sCLC_2101 (69), sCBO2173 (70), sCLC_3476 (71), sCBO3602 (72),
sCLK_1206 (73), and sCLK_3693 (74).
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wasalsoobservedtobedifferentiallyexpresseduponclindamycin
treatment (Fig. 3B). 5= rapid ampliﬁcation of cDNA ends (5=
RACE) and 3= RACE sequencing revealed a transcript length of
223nt,whichisconsistentwiththepredictionandNorthernanal-
ysis. Though computational analysis found a promoter sequence,
aShine-Dalgarnobox,andanAUGstartcodonnearthe5=endof
the transcript, the sCAC610 sequence contains several stop
codonsinthetranscript,andtherefore,itisunlikelythatsCAC610
codes for a small protein. sCAC610 was predicted to have a stable
secondary structure (see Fig. S3 in the supplemental material),
which is often observed in many prokaryotic noncoding RNAs.
TheselinesofevidencesuggestthatsCAC610isanoncodingRNA.
Northern analysis of the downstream gene (CAC0528) coding
fortheABCtransportergeneshowedincreasedexpressionofsev-
eral transcripts in cells treated with clindamycin. Although the
expected 1,470-nt transcript for CAC0528 did not show differen-
tial expression upon clindamycin treatment, three other tran-
scripts (of ca. 1,700 nt, 2,000 nt, and 2,800 nt) hybridizing to the
probe were apparently induced by clindamycin treatment
(Fig. 3B). The ~2,000-nt transcript appeared to be the most sig-
niﬁcantly and speciﬁcally induced transcript upon clindamycin
treatment.Multiplerho-independentterminatorswereidentiﬁed
by TransTermHP after the annotated CAC0528 coding region
(Fig. 3C); this suggests that there may be multiple transcripts ex-
presseduponclindamycintreatment.Allobservedtranscriptsizes
(Fig. 3B) are close to those predicted (1,700 nt, 2,110 nt, and
2,730nt)basedonthealternatetranscriptionalterminators.How-
ever, these extended transcripts contain many stop codons, and
thus are unlikely to code for different proteins. We conﬁrmed the
presence of several longer transcripts by 3= RACE analysis using
probesoutsidetheCAC0528openreadingframe(ORF)(datanot
shown). The mechanism by which this sRNA may be impacting
the expression of CAC0528 remains to be investigated. Most
sRNAsimpactmRNAexpressionbyanantisensemechanism.We
did not ﬁnd antisense pairing sequences between sCAC610 and
the coding part of the downstream CAC0528 mRNA. We did no-
tice, however, a good set of pairing sequences (see Fig. S3 in the
supplemental material) that could affect the stability of the loop
structures that correspond to the ﬁrst three putative rho-
independent terminators shown in Fig. 3C.
sCAC610isnottheonlysRNApredictedtobenearABCtrans-
porter genes. In fact, we found sRNA enrichment in intergenic
regions upstream or downstream of other ABC transporter genes
in the list of predicted clostridial sRNAs (highlighted lines in Ta-
ble S1 in the supplemental material). For example, for C. botuli-
num A3 Loch Maree, we predicted 25 sRNAs near ABC trans-
porter genes. Taking into account the number of annotated ABC
transporter genes (214), the number of predicted sRNAs (249),
and the total number of genes (3,984) on C. botulinum A3 Loch
Maree genome, Fisher’s exact test gave a signiﬁcant P value of
0.005. Signiﬁcant enrichment was also observed for C. botuli-
num E3-Alaska-E43 (P value of 0.01), C. difﬁcile 630 (P value of
0.02),C.botulinumAHall(Pvalueof0.04),andC.botulinum
AATCC19397(Pvalueof0.05).Theotherannotatedclostridial
genomes,withtheexceptionsofC.cellulolyticumH10andC.ther-
mocellum ATCC 27405, also contain many sRNA/ABC trans-
porter pairs, though not as many as in the strains above.
MostpredictedclostridialsRNAsarenotconservedinbacilli
or other genera. To date, most known sRNAs are highly con-
served in several genera. We suspected that predictions based on
closelyrelatedgenomesmightimpacttheabilitytopredictsRNAs
andtherefore,thatcurrentmethodsofpredictionmightunderes-
timate the number of sRNAs. We therefore examined conserva-
tion of sRNAs in different clostridial genomes and in clostridial
FIG 2 Northern analysis of predicted sRNAs. Validation of expression for a
selectsetofsRNAsinC.acetobutylicumandC.botulinumbyNorthernanalysis
usingsingle-strandedoligonucleotideprobes.RNAfrompoolCAC2wasused
for the C. acetobutylicum sRNAs, and RNA from pool CLK was used for the
C. botulinum sRNAs. These RNA pools are described in Text S2 in the supple-
mental material. Ethidium bromide gels of 16S RNA are shown as qualitative
and approximate loading controls. (A) Four predicted sRNAs from C. aceto-
butylicum (sCAC1449, sCAC1760, sCAC3821, and sCAC3340). (B) Two pre-
dictedsRNAsfromC.botulinumA3LochMaree(sCLK_200andsCLK_3105).
(C) The predicted sCAC137 was validated with Northern analysis using a
single-stranded oligonucleotide probe. The upstream annotated tRNA,
CACt008, was also probed to conﬁrm the tRNA size using a single-stranded
oligonucleotide probe.
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113 predicted sRNAs in C. acetobutylicum ATCC 824 against pro-
karyotic chromosomes in the NCBI genome database (E value of
0.001) found only 38 conserved sequences in nonclostridial or-
ganisms. However, of the 32 Rfam annotated sequences we pre-
dicted in C. acetobutylicum ATCC 824, 25 were included in these
38 conserved sequences and most of these 25 sequences are ribo-
switches such as SAM, T-box, or TPP, which function by binding
to small target molecules. We believe that this is because the
sRNAs covered by Rfam usually belong to common sRNA fami-
lies, which are conserved in multiple genera. In the aforemen-
tioned 38 conserved sequences, only 17 were conserved in bacilli,
whicharemembersofthephylumFirmicutesandphylogenetically
closelyrelatedtoclostridia.Usingourapproach,wealsoexamined
sRNA predictions in B. subtilis; conserved IRs between B. subtilis
and clostridial genomes rather than between the genomes of dif-
FIG3 Expression of sCAC610 and CAC0528 in response to clindamycin treatment of C. acetobutylicum cultures. A single-stranded oligonucleotide probe was
used in Northern analysis of sCAC610, and a double-stranded oligonucleotide probe was used for CAC0528. (A) Relative expression, by Q-RT-PCR analysis, of
sCAC610 and CAC0528 upon clindamycin treatment, compared to untreated cells. The cells were treated with vehicle (no-clindamycin control) or with 50, 75,
and 100 g/ml clindamycin for 30 and 60 min. (B) Differential expression of sCAC610 and CAC0528 was conﬁrmed using Northern analysis. The cells were
treated with 50 g/ml clindamycin for 30 and 60 min or not treated with clindamycin (0 g/ml). Ethidium bromide gels of 16S RNA are shown as qualitative
loadingcontrols.(C)Predictedrho-independentterminatorsdownstreamofCAC0528.(D)DNAsequenceoftheentireintergenicregionupstreamofCAC0528.
The sCAC610 transcript determined by the 5= and 3= RACE reactions is shown in bold type.
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dicted that only eight sRNAs were conserved in B. subtilis and
clostridia (Fig. 4A), all of which have
been annotated in the Rfam database.
Thus, the great majority of predicted
clostridialsRNAsequencesarenotcon-
servedinbacillioracrossmoredistantly
related genera.
Further analysis of conservation of
predictedsRNAsamongvariousspecies
within the Clostridium genus showed
much better conservation among func-
tionally related clostridia, such as
among pathogenic species (Fig. 4). For
example, among the three pathogens
(C. difﬁcile 630, C. botulinum A3 Loch
Maree, and C. perfringens 13) shown in
the Venn diagram in Fig. 4B, 204 (max-
imum number) (minimum number,
132;seethelegendtoFig.4)totalsRNA
sequencesareconserved.Thispreserva-
tion is quite high for any combination
of two or three clostridial species (data
not shown) except for cellulolytic clos-
tridia (Fig. 4E), for which we have pre-
dicted a much lower number of sRNAs.
Based on the data shown in Fig. 4 and
other data (not shown), about half of the
predictedclostridialsRNAsareconserved
among most (but not all) clostridial
strains.Onewouldthenconcludethatin-
cluding even a few clostridial genomes in
the prediction effort would generate a
largenumberofsRNApredictions.Thisis
in contrast to what would have been pre-
dicted by employing less-related ge-
nomes, as our computational results dis-
cussed above have shown. Still, the larger
the number of clostridial genomes in-
cluded in the prediction method, the
larger the number of predicted sRNAs.
Biological function and then ge-
nomesize,butnotphylogeneticclose-
ness,maycorrelatewiththenumberof
sRNAs on a genome; there are more
sRNAs in pathogenic clostridia. We
did not ﬁnd a correlation between the
number of conserved sRNA sequences
and the 16S rRNA-based phylogenetic
distance in clostridial genomes (see
Fig. S4 in the supplemental material).
This is best demonstrated by Clostrid-
ium difﬁcile. The phylogenetic distance
between C. difﬁcile and other patho-
genic clostridia is larger than the phylo-
genetic distance between strains in the
nonpathogenic clostridial categories in
thisstudy(41).However,amuchlarger
number of sRNAs was still predicted in
C. difﬁcile than in other nonpathogenic
strains with similar genome size. We noticed that there is a good
correlation between the physiological function or niche of the
FIG 4 Conservation of predicted sRNAs in different clostridial species. (A) The number of predicted
sRNAs in representative strains that are conserved in other clostridial species which includes all sub-
strains.ThenumberinparenthesesnexttothestrainnameisthetotalnumberofpredictedsRNAsineach
strain. (B to E) sRNA conservation between different clostridial species. Because an sRNA sequence may
have multiple conserved sequences in another organism, the number of sRNAs conserved between two
organisms could vary. The common number of sRNA sequences between the three species in each Venn
diagramisthemaximumnumberofconservedsRNAsinthethreespecies,andthenumberinparentheses
is the minimum number of conserved sRNAs in the three species.
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the similar genome sizes, we predicted a much larger number of
sRNAsforpathogenicclostridiathanforcellulolyticclostridiaand
solventogenic clostridia (which we grouped functionally with
C. kluyveri) (Table 1 and Fig. 5). This indicates a good correlation
betweenthephysiologicalfunctionornicheofthespeciesandthe
numberofpredictedandconservedsRNAs.Thelargernumberof
predicted sRNAs in pathogenic clostridial strains than in other
strainsdidnotarisefromthedifferenceingenomicGCcontentor
gene densities either. The genomes of pathogenic clostridia have
GC contents of ~29%, the solventogenic and C. kluyveri genomes
have GC contents of ~30%, and the cellulolytic clostidrial ge-
nomes have higher GC contents of ~35% to 40%. Higher GC
content may result in more predicted terminators and thus affect
thenumberofpredictablesRNAs.Ourpredictionsgoagainstthis
possible impact of the GC content: pathogenic clostridia have the
most predicted sRNAs, and cellulolytic the least. The gene densi-
ties in different clostridial genomes are quite close to each other
(less than 5% difference). Though the average IR size varies with
species (Table 1), it is unlikely that the IR size is the cause of the
differences in the number of predicted sRNAs. For example, the
genome size and average IR size of C. thermocellum ATCC 27405
are similar to those of C. botulinum strains, but there are many
more predicted sRNAs for C. botulinum strains.
The much larger number of predicted sRNAs in pathogenic
clostridial genomes did not result from using a larger number of
pathogenic genomes. When we repeated the prediction by keep-
ing only three randomly chosen pathogenic genomes of different
species, for every combination of three pathogenic genomes, we
still predicted more than 95% of the sRNAs we predicted when
using all pathogenic genomes. However, we found a correlation
between the number of predicted sRNAs and sequence conserva-
tion of the genomic IRs. In pathogenic clostridial genomes, the
number of conserved IRs found by BLAST is much higher than
those in solventogenic, C. kluyveri, and cellulolytic clostridial ge-
nomes. For example, using BLAST analysis, we found 644 non-
overlapping conserved sequences when we compared the C. bot-
ulinum A 3502 IRs against those in C. difﬁcile 630. In contrast, we
found only 167 nonoverlapping conserved sequences when we
compared the C. acetobutylicum ATCC 824 IRs against those in
C. kluyveri DSM 555. This ratio (644/167) is considerably higher
than the corresponding ratio of predicted sRNAs (219/113). This
would suggest that higher conservation of IR sequences does not
translate to a proportionally higher number of predicted sRNAs.
Thus, it is not logical to argue that the higher degree of IR conser-
vation among pathogenic genomes per se is the reason for the
signiﬁcantlylargernumberofpredictedsRNAsonpathogenicge-
nomes.Forpathogenicclostridia,thenumberofpredictedsRNAs
correlatedwellwithgenomesize(Fig.5),andthesamemaybetrue
for solventogenic clostridia and the physiologically related
C. kluyveri (Fig. 5). The large number (336) of sRNAs predicted
for C. beijerinckii makes the point that prediction of a large num-
ber of sRNAs for a genome does not necessarily require a large
number of functionally related genomes. This may then argue for
the interpretation that the low number of sRNAs predicted on
cellulolytic genomes is not due to the small number (3) of such
genomes included in the analysis and would support the hypoth-
esis that the number of sRNAs that are coded on a genome is
indeed related to the physiology of the organism.
DISCUSSION
We reported the prediction of a large number of sRNAs on most
sequenced clostridial genomes. In addition to the pairwise ge-
nome comparisons, we also used promoter and terminator infor-
mation in predicting clostridial sRNAs. Computationally pre-
dicted promoters and terminators provide another layer of
informationforsRNApredictions.ThepredictedsRNAsincluded
most previously predicted (Rfam database) sRNAs, but, signiﬁ-
cantly,identiﬁednovelsRNAsthatarenotwellconservedinother
prokaryotes.
Many predicted sRNA sequences were tested using Q-RT-
PCR, and a subset of these sequences were tested by Northern
analysis. In the laboratory, we tested Clostridium acetobutylicum
RNA samples from cells growing under normal culture condi-
tions, butanol stress, and butyrate stress. For Clostridium botuli-
num, we tested only samples from cells growing under normal
culture conditions. Thus, because of the limited growth condi-
tions we tested, the inability to experimentally verify the presence
of some predicted sRNAs does not necessarily mean that these
predicted sRNAs do not exist, as they could be transcribed at ex-
tremely low levels or not transcribed at all under the culture con-
ditions employed in this study. Overall, our experience is that
using Q-RT-PCR (as in Fig. 1) as the ﬁrst screen for predicted
sRNAs seems to be sound and useful.
We have also shown that the primary sequences of most pre-
dicted sRNAs are conserved only within the genus Clostridium.
OuranalysisshowsthatthenumberofpredictedsRNAsinB.sub-
tilis that are conserved in clostridial genomes is limited to only
eight sRNAs, a much smaller number than might have been ex-
pected for two closely related genera. This may be due to the dif-
ferentphysiologicalnichesoforganismsinthetwoclasses/genera,
FIG 5 Number of predicted sRNAs versus genome size. The number of
predicted sRNAs for each clostridial species is plotted against the size of its
genome. The number of predicted sRNAs in pathogenic clostridial strains
varies linearly with genome size (R2  0.8901). For species with similar ge-
nome sizes (shown within the dashed-line box), the number of predicted
sRNAs varies systematically with the type (grouped based on physiological
niche)ofclostridialspecies:verylowincellulolyticspecies,highforpathogenic
species, and intermediate for solventogenic and C. kluyveri (this is statistically
signiﬁcant; the t test comparing any two of the three clostridial types gives
P values of 0.005).
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thanclostridia,afterthe“greatoxidation”event(19),andsuggests
a relatively low conservation of many sRNAs even in evolutionar-
ily close genera. Within the genus Clostridium, our analysis shows
that many sRNAs are well conserved in several clostridial species
and that conservation is higher in physiologically related species,
such as among pathogens (Fig. 4). This means that the algorithm
would have predicted a large number of sRNAs even if only three
pathogenic clostridial gnomes were included in the analysis and
thatthesmallnumberofsRNAspredictedamongcellulolyticclos-
tridial genomes would not dramatically increase by including ad-
ditional cellulolytic genomes. What would be the reason for
pathogens to carry genes encoding more sRNAs? Perhaps the rea-
sonisthatthenicheoftheseorganismsashumanoranimalpatho-
gens requires larger ﬂexibility in adapting to changing host envi-
ronments to give them a survival advantage and perhaps their
pathogenic potency. It has been reported that the expression of
some sRNAs is induced by the host environment (42, 43). What
does the low number of predicted sRNAs suggest for cellulolytic
clostridial species? Perhaps that their environmental niche is very
predictableandsecureintermsofnutrientresourcesandthatthey
have relatively little competition from other organisms.
Few sRNAs impacting drug resistance have been discovered.
These sRNAs include micF, whose transcriptional activation is
associated with resistance to multiple antibiotics (44, 45), and an
sRNA which confers drug resistance to spectinomycin in E. coli
(46). An ABC transporter gene has been reported to be trans-
regulated by an sRNA which folds as a pseudoknot and binds Hfq
protein in E. coli, Salmonella, and Shigella (47). It has also been
reported that sRNAs are encoded within pathogenicity islands in
Staphylococcusaureus(48),butthestudydidnotexaminewhether
these sRNAs are involved in regulating drug resistance or not.
Here, the discovery of the clindamycin-responsive sRNA
(sCAC610) in C. acetobutylicum, which is strongly conserved in
other clostridial genomes (C. beijerinckii and several strains of
C. botulinum), suggests that this sRNA plays an important role in
drug resistance. We do not have evidence that sCAC610 works
with the putative RNA chaperone Hfq protein (coded by
CAC1834) in C. acetobutylicum. However, we observed that
sCAC610 displays a consistent location and distance to its down-
streamputativeABCtransportergeneinallthegenomesinwhich
it was identiﬁed. It is noteworthy that the ABC transporter gene
CAC0528 is conserved in many bacteria other than clostridia. In
contrast, sCAC610 is a unique sequence found only in the C. bot-
ulinum, C. acetobutylicum, and C. beijerinckii genomes. The en-
richment of predicted sRNAs in upstream and downstream re-
gions of other ABC transporter genes suggests that sRNAs could
bebroadlyinvolvedincis-regulationofefﬂuxpumpactivity.Since
it is well established that efﬂux pumps regulate clinically relevant
resistance to antibiotics (49, 50), our ﬁndings provide a new per-
spective for future research into mechanisms responsible for an-
tibiotic resistance. Finally, our study did not predict any sRNA
within the pathogenicity islands of pathogenic clostridial ge-
nomes.
MATERIALS AND METHODS
ComputationalidentiﬁcationofsRNAsencodedonintergenicregions.
The sequences of all 21 clostridial genomes (Table 1) were downloaded
from NCBI (ftp://ftp.ncbi.nih.gov/). tRNAs, rRNAs, previously anno-
tated small RNAs (sRNAs), and riboswitches were downloaded from the
Rfam database (http://www.sanger.ac.uk/Software/Rfam/) (51). Genetic
features used in the prediction of sRNAs include conserved intergenic
regions (IRs), rho-independent terminators, and predicted promoters
targeted by clostridial sigma factors A, D, E, and F. The computed
data for these features were prepared as described below. IR sequence
conservation data were prepared by pairwise genome comparisons. For
sRNA predictions, to avoid predicting obvious conservation between
strainsofthesamespecies,thegenomesofallotherclostridialspecieswere
used as its comparative partner genomes. For example, the Clostrid-
ium botulinum strains were not compared to each other, but to all other
strains. Because sRNAs are usually 50 to 550 nt in length, we were inter-
ested only in IR sequences longer than 50 nt. We identiﬁed the conserved
IRs between the target genome and its partner genome with WU BLAST
2.0(52).ABLASTEvaluecutoffof11010wasapplied,whichassesses
the signiﬁcance of an alignment. Though a number of repeat regions are
found in the IRs of prokaryotic genomes, we did not remove such repeats
because these repeats may carry functional sequences. Putative IR rho-
independent transcription terminators were predicted with TransTerm
(53) and RNAMotif (54). For TransTerm, we used only those rho-
independent terminators that had a conﬁdence of 96% or higher in the
terminator prediction. For RNAMotif, we used the descriptor ﬁle in-
cluded in the sRNAPredict2 (55) package. Clostridial promoters targeted
by A, D, E, and F were predicted using a hidden Markov model (56).
After collecting the data described above for each genome, we applied
sRNAPredict2(55)tocombinethecomputedfeaturesandpredictsRNAs
on each genome. The following criteria were used in the prediction: (i)
everysRNAcandidatemusthaveaputativeterminatornomorethan20nt
downstream of its 3= end; (ii) every sRNA candidate must be conserved
and predicted on at least two clostridial genomes of different species. We
also predicted sRNAs on the B. subtilis genome using the approach de-
scribed above, except that the prediction examined conservation of IR
sequencesbetweenB.subtilisandclostridialgenomesratherthanbetween
different bacillus genomes.
Shine-Dalgarno(SD)sequenceswerepredictedwiththeprogramfree
_align described in reference 32. This program simulates the binding be-
tween mRNAs and single-stranded 16S rRNA 3= tail and identiﬁes SD
sequencesbythepositionofthelowestG°value.TheG°wascalculated
between the 16S 3=-tail sequence 5=-GAUCACCUCCUUUCU-3= and the
5= end (1b pt o45 bp) of the predicted sRNA sequences. If G° is less
than 3.4535 kcal/mol, the transcript was assumed to have an SD se-
quence. Translation start codons (AUG, GUG, and UUG) were then
searched for within 20 bp downstream of the predicted SD sequence.
PredictedsRNAschosenforexperimentalvalidationwerefurtherclas-
siﬁed into functionally known sRNA families using GraPPLE. The sRNA
family with the largest probability was reported as the family that each
sRNA belongs to. sCAC610 was also analyzed for riboswitch elements
using several online computational tools (57–59).
sRNA nomenclature. A predicted sRNA on a genome is indicated by
an initial lowercase “s,” followed by the three-letter (capitalized) genome
identiﬁcation(ID)usedintheKEGGdatabase,andendingwithanumber
thatindicatesitsgenomiclocation,speciﬁcally,itsgenomicleftcoordinate
(in kb units) plus one, regardless of its orientation. For example, the
C.acetobutylicumsRNAthatstartsfromchromosomecoordinate3,500is
named sCAC4; the sRNA that starts from the C. acetobutylicum pSOL1
megaplasmid coordinate 600 is designated sCA-P1.
Strains and growth conditions. C. acetobutylicum was grown as re-
portedpreviously(34).C.botulinumstrainsweregrowninEricJohnson’s
lab (University of Wisconsin, Madison). C. botulinum strains A ATCC
3502 and A Hall were grown in type A toxin production medium (60).
C. botulinum strain A3 Loch Maree was grown in MM medium (61, 62).
Cultures to collect cell samples for RNA isolation. In order to vali-
date predicted sRNAs, we collected cells for RNA extraction as follows.
For Clostridium acetobutylicum, cultures were grown under three condi-
tions: no stress, butanol stress (0.5% [vol/vol]), and butyric acid stress
(0.35% [vol/vol]). These cultures were meant to provide RNA that might
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genome, based on the assumption that some of the sRNAs are expressed
under some physiologically encountered stress, such as metabolite (buta-
nol or butyrate) stress. A ﬂask of 250 ml of clostridial growth medium
(CGM)wasinoculatedwith10ml(4%vol/vol)ofprecultureatanA600of
0.6 to 0.8. This culture was grown to an A600 of ~0.6 and then used to
inoculate 12 subcultures of 50 ml each with a 10% (vol/vol) inoculum.
Four of these subcultures were allowed to grow unstressed, four were
stressed with butyrate, and four were stressed with butanol. For butyrate
stress, 175 l of butyric acid was added at an A600 of 0.8, and for butanol
stress, 250 lo fn-butanol was added at an A600 of 0.8. For the unstressed
cultures, RNA samples were taken at 6 h (exponential phase), 12 h (tran-
sition phase), 18 h (early stationary phase), and 30 h (late stationary
phase). For the stressed cultures (butanol and butyrate), RNA samples
were taken 30 min and 1 h after stress.
To examine the effect of clindamycin on C. acetobutylicum, two bio-
logicalreplicate250-mlﬂaskcultureswereinoculatedwitha4%(vol/vol)
preculture at an A600 of ~0.6 and grown to an A600 of ~1.0. Aliquots of
10 ml of culture were then transferred to duplicate individual ﬂasks con-
taining the following concentrations of clindamycin (Sigma-Aldrich):
0, 50, 75, and 100 g/ml. RNA samples were taken 30 min and 1 h after
stress.
C. botulinum strains were grown in 500-ml static ﬂasks without stress
with a 1% (vol/vol) inoculum as described previously (63). C. botulinum
cultures were sampled at 4, 5, 6, 8, 10, 12, and 24 hours during growth.
Culture aliquots were ﬂash-frozen and stored in liquid nitrogen until
RNA preparation.
RNA sampling and isolation. For details on RNA sampling and iso-
lation, see Text S2 in the supplemental material.
RNApools.ForinformationonRNApools,seeTextS2inthesupple-
mental material.
cDNAgenerationandQ-RT-PCRanalysis.FordetailsoncDNAgen-
erationandQ-RT-PCRanalysis,seeTextS2inthesupplementalmaterial.
Northernanalysis.Northernblotsusingasingle-strandedoligoprobe
were performed as described previously (29). Oligonucleotide sequences
used are listed in Table S2 in the supplemental material. In each lane of
the Northern blot, 20 g of total RNA was loaded and electrophoretically
resolved on a 1.2% denaturing morpholinepropanesulfonic acid
(MOPS)-agarose gel. RNA markers, 0.1 to 1 kb and 0.2 to 10 kb (USB,
Cleveland, OH) were used as size standards. Northern blotting using
double-stranded DNA (dsDNA) probes was performed as described pre-
viously (29) with a few modiﬁcations. Unincorporated radiolabeled
[-32P]dCTP was removed using Illustra G-50 spin columns (GE, Pisca-
taway, NJ). Prehybridization and hybridization were carried out at 42°C
with ULTRAhyb hybridization buffers (Ambion).
RACE reactions (5= RACE and 3= RACE). For details on rapid ampli-
ﬁcation of cDNA ends (RACE), see Text S2 in the supplemental material.
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